ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $254,128 | -54.3% | 46,629 | -43.7% | 0.00% | 0.0% |
| Q2 2023 | $555,783 | -28.3% | 82,829 | -5.7% | 0.00% | -50.0% |
| Q1 2023 | $775,530 | +12.3% | 87,829 | -2.8% | 0.00% | 0.0% |
| Q4 2022 | $690,366 | -62.9% | 90,362 | -65.4% | 0.00% | -66.7% |
| Q3 2022 | $1,859,000 | -23.9% | 261,152 | -13.5% | 0.01% | -25.0% |
| Q2 2022 | $2,443,000 | +31.8% | 301,951 | +126.1% | 0.01% | +60.0% |
| Q1 2022 | $1,854,000 | -77.4% | 133,563 | -34.4% | 0.01% | -76.2% |
| Q1 2021 | $8,200,000 | +2377.3% | 203,685 | +3537.2% | 0.02% | +2000.0% |
| Q4 2020 | $331,000 | – | 5,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |